FDA 483 Response for Drug GMP Inspections demo

A Form 483 response that checks each sentence against the records, traces the full extent across lots, batches and clients, and keeps each promise. 1:29

What the demo shows

An FDA 483 response solution for drug GMP inspections that answers each observation in full.

Agents turn each observation into the claims it makes, check each claim against the record it names, and trace every affected lot through lot issues and scanned logbooks to the batches made with it and where each one is now. A response writer drafts in the order FDA's reviewer reads, every sentence cited, and a challenger reads the draft as that reviewer would, the team's own overclaims included. Each commitment date is accepted or moved by its owner, the plant QA head signs each section after opening the exhibits, and each client receives a notice limited to its own products.

Transcript

  1. FDA 483 Response for Drug GMP Inspections answers each observation, for drug substance plants.
  2. FDA weighs answers sent within fifteen business days; three remain.
  3. Agents split Observation 1 into claims, and check each one.
  4. One is not in our records: the batch record shows fresh solvent.
  5. The challenger reads it as FDA would: what about the earlier lots?
  6. The extent tracer widens it to twenty-seven lots and thirty-one batches.
  7. It attaches the hold record, and catches the team's own overclaim in the draft.
  8. Recovered toluene joins the answer; the CAPA owner moves his date to January thirtieth.
  9. Marthe, the Plant 5 QA head, opens the extent table and the peroxide results herself, then signs the section; nobody here ever approves their own work.
  10. Promises kept on time, each client told its own part first, new coordinators answering like veterans.
  11. Built on Botminds: agents, data, screens and governance on one platform.

The narration as written for the film. Captions are on the player.